Nicotine therapeutic benefits: Difference between revisions

Line 690: Line 690:




======2021: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186418/ A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes]===
===2021: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186418/ A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes]===
*An estimated 60%–90% of people with schizophrenia smoke, compared with 15%–24% of the general population, exacerbating the already high morbidity and mortality rates observed in this population.
*An estimated 60%–90% of people with schizophrenia smoke, compared with 15%–24% of the general population, exacerbating the already high morbidity and mortality rates observed in this population.
*Pilot Study - only 40 participants
*Pilot Study - only 40 participants